FDA-approved option for adult and pediatric patients available in 15 mM per 5 mL, 45 mM per 15 mL and 150 mM per 50 mL presentations LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today ...

Potassium phosphates injection had a market value of approximately $50.7 million for the 12 months ending January 2026, per ...

in intravenous fluids to correct hypophosphatemia in adults and pediatric patients when oral or enteral replacement is not possible, insufficient or contraindicated for parenteral nutrition in adults ...

Potassium Phosphates Injection is a phosphorus replacement product. Fresenius Kabi announced the immediate availability of Potassium Phosphates Injection in 3 presentations: phosphorus 15mmol/5mL and ...

Credit: Getty Images. The FDA has issued a safety alert regarding the use of unapproved potassium phosphates drug products in pediatric patients. The Food and Drug Administration (FDA) has issued a ...

American Regent is offering Potassium Phosphates Injection, which is the generic of Potassium Phosphates. Potassium Phosphates Injection is indicated as a source of phosphorus in intravenous fluids to ...